跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 65,260 条关于
“GEMINI-2”
全部
65,260
临床试验
42,621
药物
7,337
机构
1,392
资讯
13,910
9个月前
Zasocitinib Shows Phase 3 Superiority Over Apremilast in Dermatology Trials
9个月前
Vanda Pharmaceuticals Submits BLA for Imsidolimab to Treat Rare Generalized Pustular Psoriasis
4年前
FDA Approves First Eye Drops for Presbyopia Treatment, Offering Alternative to Reading Glasses
2年前
Tolebrutinib Shows Promise in Slowing Disability Progression in Non-Relapsing Secondary Progressive MS
去年
Vanda Acquires Global Rights to Imsidolimab for GPP in $50 Million Deal with AnaptysBio
去年
Sanofi's Tolebrutinib Shows Promise in Non-Relapsing Secondary Progressive MS
去年
Google DeepMind Unveils TxGemma: Open AI Models to Accelerate Drug Discovery
2年前
BTK Inhibitors Show Promise and Face Challenges in Multiple Sclerosis Trials
上个月
Revelation Biosciences Secures FDA Agreement for Adaptive Phase 2/3 Trial of Gemini in Acute Kidney Injury
上个月
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study of Gemini in Acute Kidney Injury
第 1 页,共 1391 页
上一页
下一页